25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma

• Published in: PloS one 2016-10, Vol.11 (10), p.e0164550-e0164550
• Main Authors: Danilovic, Debora Lucia Seguro, Ferraz-de-Souza, Bruno, Fabri, Amanda Wictky, Santana, Nathalie Oliveira, Kulcsar, Marco Aurelio, Cernea, Claudio Roberto, Marui, Suemi, Hoff, Ana Oliveira
• Format: Article
• Language: English
• Subjects: 25-Hydroxyvitamin D; Adult; Aged; Benign; Biology and Life Sciences; Breast cancer; Cancer; Cancer metastasis; Cancer research; Carcinoma; Carcinoma - metabolism; Carcinoma - pathology; Carcinoma, Papillary; Colon; Comparative analysis; Cross-Sectional Studies; Drug dosages; Endocrinology; Female; Health aspects; Health risks; Humans; Leukemia; Lymph nodes; Lymphatic Metastasis; Male; Medical diagnosis; Medical prognosis; Medicine and Health Sciences; Metastases; Metastasis; Middle Aged; Nodules; Nutrient deficiency; Papillary thyroid carcinoma; Patients; Physical sciences; Prognosis; Prostate; Quartiles; Retrospective Studies; Risk analysis; Risk assessment; Risk Factors; Studies; Surgery; Systematic review; Thyroid; Thyroid cancer; Thyroid Cancer, Papillary; Thyroid Neoplasms - metabolism; Thyroid Neoplasms - pathology; Thyroid-stimulating hormone; Thyroidectomy; Thyrotropin - metabolism; Vitamin D; Vitamin D - analogs & derivatives; Vitamin D - metabolism; Vitamin D Deficiency - epidemiology; Vitamin deficiency
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0164550

The increasing incidence of thyroid nodules demands identification of risk factors for malignant disease. Several studies suggested the association of higher TSH levels with cancer, but influence of 25-hydroxyvitamin D (25OHD) is controversial. This study aimed to identify the relationship of thyroid cancer with higher TSH levels and hypovitaminosis D and to evaluate their influence on prognostic characteristics of papillary thyroid carcinomas (PTC). We retrospectively evaluated 433 patients submitted to thyroidectomy for thyroid nodules. Patients were categorized according to quartiles of TSH and 25OHD levels. Clinicopathological features were analyzed. Subjects with thyroid carcinomas were more frequently male and younger compared to those with benign disease. Their median TSH levels were higher and adjusted odds-ratio (OR) for cancer in the highest-quartile of TSH (> 2.4 mUI/mL) was 2.36 (1.36-4.09). Although vitamin D deficiency/insufficiency was prevalent in our cohort (84%), no significant differences in 25OHD levels or quartile distribution were observed between benign and malignant cases. Among 187 patients with PTC, analyses of prognostic features revealed increased risk of lymph nodes metastases for subjects with highest-quartile TSH levels (OR = 3.7, p = 0.029). Decreased 25OHD levels were not overtly associated with poor prognosis in PTC. In this cross-sectional cohort, higher TSH levels increased the risk of cancer in thyroid nodules and influenced its prognosis, particularly favoring lymph nodes metastases. On the other hand, no association was found between 25OHD levels and thyroid carcinoma risk or prognosis, suggesting that serum 25OHD determination may not contribute to risk assessment workup of thyroid nodules.